✦ LIBER ✦

Management of Metastatic Melanoma to the Breast with High-Dose Interleukin-2 and Surgical Resection

✍ Scribed by Ian K. Komenaka; Gail DeRaffele; Karl S. Hurst-Wicker; Howard L. Kaufman

Book ID: 110760570
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 45 KB
Volume: 11
Category: Article
ISSN: 1075-122X
DOI: 10.1111/j.1075-122x.2005.21627.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surgical resection of metastatic renal c

Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy

✍ Dr. Richard M. Shery; Harvey I. Pass; Steven A. Rosenberg; James C. Yang 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB 👁 2 views

Thirty-one patients with disseminated melanoma or renal cell cancer (RCC) who had a limited relapse or persistent disease after a partial or complete response to interleukin-2 (IL-z)-based immunotherapy underwent resection of progressing tumors or residual sites of disease. There were no surgery-rel

High-dose tamoxifen added to concurrent

High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma

✍ Steven J. O'Day; Peter D. Boasberg; Tim S. Kristedja; Maureen Martin; He-Jing Wa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Background: In vitro cell culture data and preclinical models suggest that tamoxifen modulates tumor cell sensitivity to a wide range of therapeutic agents. in the current study, the authors examined whether high-dose tamoxifen (hdt) improved the overall and complete response in patients with me

Comparison of acute toxicity and mortali

Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma

✍ Laura M. Alwan, Kenneth Grossmann, Daniel Sageser, Joan Van Atta… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 252 KB

A novel immunoregulatory regimen combini

A novel immunoregulatory regimen combining high dose interleukin-2 and taurolidine for the treatment of patients with progressive metastatic melanoma

✍ G. C. O’Brien; R. A. Cahill; M. J. O’Sullivan; D. J. Bouchier-Hayes; H. P. Redmo 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 242 KB

High-dose chemotherapy with heamatopoiet

High-dose chemotherapy with heamatopoietic rescue: application to primary management of metastatic breast cancer

✍ W. R. BEZWODA 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Trends in the safety of high dose bolus

Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer

✍ Udai S. Kammula; Donald E. White; Steven A. Rosenberg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## BACKGROUND. Administration of recombinant high dose interleukin-2 (IL-2) can mediate tumor regression in patients with metastatic melanoma and renal carcinoma. Significant trends in the safety of high dose IL-2 administration at a single institution over a 12-year study period were reviewed. #